1. Use of whole genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia
- Author
-
Chaidir, Lidya, Ruesen, Carolien, Dutilh, Bas E, Ganiem, Ahmad R, Andryani, Anggriani, Apriani, Lika, Huynen, Martijn A, Ruslami, Rovina, Hill, Philip C, Crevel, Reinout van, Alisjahbana, Bachti, Sub Bioinformatics, and Theoretical Biology and Bioinformatics
- Subjects
whole genome sequencing ,drug resistance ,resistance mutations ,Mycobacterium tuberculosis - Abstract
BACKGROUND: Whole genome sequencing (WGS) is rarely used for drug-resistance testing of Mycobacterium tuberculosis in high-endemic settings. We present the first study from Indonesia, which has the second highest tuberculosis (TB) burden worldwide, with less than 50% of drug-resistant cases currently detected. METHODS: We applied WGS in strains from 322 adult HIV-negative TB patients. Phenotypic DST was done for a portion of patients. RESULTS: Fifty-one isolates (15.8%) harboured drug resistance mutations, including 42 among 322 patients (13.0%) with no prior TB treatment. Eight (2.5%) isolates were multidrug-resistant (MDR), one was extensively drug-resistant (XDR). Most mutations were found in katG (n=18), pncA (n=18), rpoB (n=10), fabG1 (n=9) and embB (n=9). The agreement of WGS-based resistance and phenotypic drug susceptibility testing (DST) to first-line drugs was high for isoniazid, rifampicin, and streptomycin, and less for ethambutol. Drug resistance was more common in Indo-Oceanic lineage strains (37.5%) than Euro-American (18.2%) and East-Asian lineage strains (10.3%; p=0.044), but combinations of multiple mutations were most common among East-Asian lineage strains (p=0.054). CONCLUSIONS: Our data support the potential use of WGS for more rapid and comprehensive prediction ofDR-TB in Indonesia. Future studies should address potential barriers in implementing WGS, the distribution of specific resistance mutations, and associations of particular mutations with endemic M. tuberculosis lineages in Indonesia.
- Published
- 2019